Haruki Matsumura

This inventor holds 13 USPTO granted patents. Top assignees: Sumitomo Pharmaceuticals Company Limited, Sumitomo Chemical Company, Limited. Active years: 1985-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruki Matsumura. Retrieved from https://idiyas.com/inventor/haruki-matsumura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 126(Granted Patents)

Location History:

Osaka, JP (1985 - 1992)
Nara, JP (1989 - 1996)

Company Filing History:

12 out of 174

Sumitomo Pharmaceuticals Company Limited

patents

1 out of 6,965

Sumitomo Chemical Company, Limited

patents

Years Active: 1985-1996

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5578722 - Process for preparing carbapenem compounds (1996-11-26),

2. 5322952 - Pyrrolidine derivatives and process for preparing the same (1994-06-21),

3. 5216186 - Crystalline palladium tetrakis(triphenylphosphine) and a process for (1993-06-01),

4. 5134231 - 3(1-hydoxyethyl)azetidinone compounds and their production (1992-07-28),

5. 5122604 - .beta.-lactam compounds (1992-06-16),

6. 5112966 - Beta-lactams (1992-05-12),

7. 5093328 - Beta-lactam compounds (1992-03-03),

8. 5075435 - Beta-lactams and their production via stereospecific hydrogenation (1991-12-24),

9. 4962103 - Carbapenem compounds and production thereof (1990-10-09),

10. 4933333 - .beta.-lactam compounds (1990-06-12),

11. 4888344 - Carbapenem compound in crystalline form, and its production and use (1989-12-19),

12. 4742052 - Antibacterial .beta.-lactam compounds (1988-05-03),

13. 4536334 - Preparation of .beta.-lactam derivatives (1985-08-20),

Title: The Innovative Genius of Haruki Matsumura

Introduction

Haruki Matsumura, an accomplished inventor based in Nara, Japan, has made significant contributions to the field of pharmaceuticals through his innovative approaches to drug development. With an impressive portfolio of 13 patents, Matsumura has established himself as a prominent figure in the pharmaceutical industry.

Latest Patents

Among his notable inventions is the patent titled "Process for Preparing Carbapenem Compounds." This innovative process outlines a novel and effective method for synthesizing a carbapenem compound, utilizing specific reaction conditions that yield a compound essential for developing antibacterial agents. Additionally, he holds a patent for "Pyrrolidine Derivatives and Process for Preparing the Same," which focuses on the preparation of pyrrolidine derivatives. These derivatives serve as intermediates in creating the side chains necessary for antibacterial penem and carbapenem compounds.

Career Highlights

Haruki Matsumura has worked at esteemed companies such as Sumitomo Pharmaceuticals Company Limited and Sumitomo Chemical Company, Limited. His tenure at these organizations has facilitated his exploration and advancement in pharmaceutical research and development. His patents reflect his dedication to combating bacterial infections through innovative drug formulation techniques.

Collaborations

Throughout his career, Matsumura has collaborated with prominent figures in his field, including fellow researchers Makoto Sunagawa and Takaaki Inoue. These collaborations have undoubtedly fostered a dynamic environment for creativity and innovation, allowing them to share knowledge and push the boundaries of traditional pharmaceutical practices.

Conclusion

Haruki Matsumura is a notable inventor whose contributions have significantly impacted the pharmaceutical industry. His innovative patents, extensive career, and collaborative spirit highlight his dedication to advancing healthcare solutions and addressing critical challenges in antibacterial drug development. Through his work, Matsumura continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]